|
KHDRBS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.802000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.445000E-03 |
| Normal-vs-Stage2 |
9.443700E-02 |
| Normal-vs-Stage3 |
6.165600E-01 |
| Normal-vs-Stage4 |
1.158780E-01 |
| Stage1-vs-Stage2 |
9.299600E-01 |
| Stage1-vs-Stage3 |
1.503580E-01 |
| Stage1-vs-Stage4 |
8.160400E-01 |
| Stage2-vs-Stage3 |
3.082400E-01 |
| Stage2-vs-Stage4 |
8.689800E-01 |
| Stage3-vs-Stage4 |
4.863800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.983200E-03 |
| Normal-vs-AfricanAmerican |
1.676000E-02 |
| Normal-vs-Asian |
8.278200E-02 |
| Caucasian-vs-AfricanAmerican |
7.995200E-01 |
| Caucasian-vs-Asian |
7.642600E-01 |
| AfricanAmerican-vs-Asian |
8.064800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.638350E-04 |
| Normal-vs-Female |
7.117800E-01 |
| Male-vs-Female |
5.440700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.256500E-02 |
| Normal-vs-Extreme_Weight |
2.044900E-03 |
| Normal-vs-Obese |
2.977000E-01 |
| Normal-vs-Extreme_Obese |
1.656370E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.842600E-01 |
| Normal_Weight-vs-Obese |
1.849370E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.791800E-01 |
| Extreme_Weight-vs-Obese |
6.694000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.637600E-01 |
| Obese-vs-Extreme_Obese |
8.056400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.422000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.092050E-01 |
| Normal-vs-Age(61-80Yrs) |
7.379300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.678800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.263000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.528200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.002000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.163800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.325240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.302200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.324270E-02 |
| Normal-VS-Type2 PRCC |
2.10619999999606E-05 |
| Normal-VS-KIRP CIMP |
1.408150E-01 |
| Normal-VS-Unclassified PRCC |
3.028400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.485800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.287600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.679000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.393600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.337940E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.584000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.782900E-04 |
| Normal-vs-N1 |
2.515000E-01 |
| Normal-vs-N2 |
8.204200E-02 |
| N0-vs-N1 |
3.796300E-04 |
| N0-vs-N2 |
8.907200E-01 |
| N1-vs-N2 |
1.639960E-01 |
|
|
